Literature DB >> 18981379

Is the common LRRK2 G2019S mutation related to dyskinesias in North African Parkinson disease?

S Lesage1, S Belarbi, A Troiano, C Condroyer, N Hecham, P Pollak, E Lohman, T Benhassine, F Ysmail-Dahlouk, A Dürr, M Tazir, A Brice.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18981379     DOI： 10.1212/01.wnl.0000338460.89796.06

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  11 in total

1.  Clinical expression of LRRK2 G2019S mutations in the elderly.

Authors:  Marta San Luciano; Richard B Lipton; Cuiling Wang; Mindy Katz; Molly E Zimmerman; Amy E Sanders; Laurie J Ozelius; Susan B Bressman; Rachel Saunders-Pullman
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

Review 2.  The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews.

Authors:  Avner Thaler; Elissa Ash; Ziv Gan-Or; Avi Orr-Urtreger; Nir Giladi
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575

3.  LRRK2 G2019S mutation: frequency and haplotype data in South African Parkinson's disease patients.

Authors:  Soraya Bardien; Angelica Marsberg; Rowena Keyser; Debbie Lombard; Suzanne Lesage; Alexis Brice; Jonathan Carr
Journal:  J Neural Transm (Vienna)       Date:  2010-06-11       Impact factor: 3.575

4.  Genetic Modifiers in Neurodegeneration.

Authors:  Nimansha Jain; Alice S Chen-Plotkin
Journal:  Curr Genet Med Rep       Date:  2018-02-05

Review 5.  Gene-environment interactions: key to unraveling the mystery of Parkinson's disease.

Authors:  Hui-Ming Gao; Jau-Shyong Hong
Journal:  Prog Neurobiol       Date:  2011-03-23       Impact factor: 11.685

Review 6.  Parkinson's disease: Exit toxins, enter genetics.

Authors:  Marie Westerlund; Barry Hoffer; Lars Olson
Journal:  Prog Neurobiol       Date:  2009-11-17       Impact factor: 11.685

7.  LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease.

Authors:  Z Gan-Or; A Bar-Shira; A Mirelman; T Gurevich; M Kedmi; N Giladi; A Orr-Urtreger
Journal:  Neurogenetics       Date:  2009-05-21       Impact factor: 2.660

8.  LRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson's Disease.

Authors:  Ahmed Bouhouche; Houyam Tibar; Rafiqua Ben El Haj; Khalil El Bayad; Rachid Razine; Sanaa Tazrout; Asmae Skalli; Naima Bouslam; Loubna Elouardi; Ali Benomar; Mohammed Yahyaoui; Wafa Regragui
Journal:  Parkinsons Dis       Date:  2017-03-30

9.  Identification of Eleven Novel BRCA Mutations in Tunisia: Impact on the Clinical Management of BRCA Related Cancers.

Authors:  Yosr Hamdi; Najah Mighri; Maroua Boujemaa; Nesrine Mejri; Sonia Ben Nasr; Mariem Ben Rekaya; Olfa Messaoud; Hanen Bouaziz; Yosra Berrazega; Haifa Rachdi; Olfa Jaidane; Nouha Daoud; Aref Zribi; Jihene Ayari; Houda El Benna; Soumaya Labidi; Jamel Ben Hassouna; Abderazzek Haddaoui; Khaled Rahal; Farouk Benna; Ridha Mrad; Slim Ben Ahmed; Hamouda Boussen; Samir Boubaker; Sonia Abdelhak
Journal:  Front Oncol       Date:  2021-08-20       Impact factor: 6.244

10.  Clinical Heterogeneity Among LRRK2 Variants in Parkinson's Disease: A Meta-Analysis.

Authors:  Li Shu; Yuan Zhang; Hongxu Pan; Qian Xu; Jifeng Guo; Beisha Tang; Qiying Sun
Journal:  Front Aging Neurosci       Date:  2018-09-19       Impact factor: 5.750
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.